Blue Biotechnology Study

Project Service:

Studies & Policy Advice

Service duration: April – December 2013
In close cooperation with its consortium partners, s.Pro has been responsible for:
  • Performing comprehensive patent profiling in the field of blue biotechnology
  • Developing a stakeholders database
  • Producing a global preliminary report on pharmaceuticals and cosmetics
  • Mapping and analysis of relevant EU research projects (FP6, FP7, Horizon 2020)
Funding programme: 
Lead partner: 
Total budget: 
Total duration: 
October 2013 – April 2014
Under a Service Framework Contract with the EU Commission / DG MARE, s.Pro is part of the ECORYS/s.Pro/MRAG consortium that has developed the “Study in support of impact assessment work on Blue Biotechnology”.

The main purpose of the study has been to assist stakeholders to fully deliver on the potential of Blue Biotechnology for growth and jobs, by promoting the sector’s sustainability, competitiveness and visibility.

To support the European Commission’s impact assessment on Blue Biotechnology, this study has provided key information, data and specific analysis on the growth potential of the Blue Biotechnology sector.

Based on a comprehensive stakeholder mapping and the results of the EU Commission’s consultation process, the consortium under the lead of MRAG produced recommendations on three policy options in the field of Blue Biotechnology, ranging from no policy change to soft policy framework and consolidated European strategy.

Blue Biotechnology has been highlighted as one of the five blue growth focus areas in the 2012 European Commission strategy. In particular, it called for strengthened efforts to find competitive niches such as high-value products for the health, cosmetic and other industrial biotechnology sectors.